Tamoxifen treatment and risk of deep venous thrombosis and pulmonary embolism

Abstract

The findings of the current study suggest that the first 2 years after the initiation of tamoxifen therapy may be the most crucial time for monitoring DVT/PE risk, particularly in older women.